The identification of promising and shared therapeutic targets, such as DPP-4, GLP-1R, and TrκB, in different diseases, such as AD, PD, and HD, suggest its importance in therapeutic approaches to NDs. The gene discussed is NTRK2; the disease is Huntington disease.